Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider

Stock News

Oct 09

AUSTAR (06118) saw its gains expand to over 54% in late trading session. As of press time, the stock was up 48.04% to HK$1.51, with trading volume reaching HK$8.4778 million.

According to public information, Hong Kong Austar Group operates as a technology-based pharmaceutical engineering solutions provider. As one of the group's main subsidiaries, Austar Life Sciences Products and Services Division encompasses nine business segments: sterile drug production contamination control consumables, equipment and services; environmental monitoring and detection systems; validation and stand-alone equipment; biological upstream process systems; single-use process systems; laboratory informatization; and life science consulting.

AUSTAR's interim results showed shareholders' attributable profit of HK$24.999 million, representing a year-on-year increase of 325.37%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1153456278"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153456278\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153456278?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-09 16:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153456278","market":"sh","top_or_hot":-1,"title":"Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider","media":"Stock News","content":"<p>AUSTAR (06118) saw its gains expand to over 54% in late trading session. As of press time, the stock was up 48.04% to HK$1.51, with trading volume reaching HK$8.4778 million.</p>\n<p>According to public information, Hong Kong Austar Group operates as a technology-based pharmaceutical engineering solutions provider. As one of the group's main subsidiaries, Austar Life Sciences Products and Services Division encompasses nine business segments: sterile drug production contamination control consumables, equipment and services; environmental monitoring and detection systems; validation and stand-alone equipment; biological upstream process systems; single-use process systems; laboratory informatization; and life science consulting.</p>\n<p>AUSTAR's interim results showed shareholders' attributable profit of HK$24.999 million, representing a year-on-year increase of 325.37%.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-09 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AUSTAR (06118) saw its gains expand to over 54% in late trading session. As of press time, the stock was up 48.04% to HK$1.51, with trading volume reaching HK$8.4778 million.</p>\n<p>According to public information, Hong Kong Austar Group operates as a technology-based pharmaceutical engineering solutions provider. As one of the group's main subsidiaries, Austar Life Sciences Products and Services Division encompasses nine business segments: sterile drug production contamination control consumables, equipment and services; environmental monitoring and detection systems; validation and stand-alone equipment; biological upstream process systems; single-use process systems; laboratory informatization; and life science consulting.</p>\n<p>AUSTAR's interim results showed shareholders' attributable profit of HK$24.999 million, representing a year-on-year increase of 325.37%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06118","symbol_name":"奥星生命科技","start_time":0,"source_url":"","article_id":"1153456278","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153456278","pubTimestamp":1759997125,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"AUSTAR (06118) saw its gains expand to over 54% in late trading session. As of press time, the stock was up 48.04% to HK$1.51, with trading volume reaching HK$8.4778 million. According to public...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06118":"奥星生命科技","01477":"欧康维视生物-B","BK1141":"生命科学工具和服务","07226":"南方两倍做多恒科","BK4614":"Manus概念股","HSCEI":"国企指数","YANG":"三倍做空富时中国ETF-Direxion","BK1191":"制药","BK1574":"生物医药B类股"},"translate_title":"港股快讯|奥星(06118)尾盘大涨超54%奥星集团担任科技型制药工程解决方案提供商","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01477":1,"06118":1,"07226":1,"HSCEI":1,"YANG":1},"content_text":"AUSTAR (06118) saw its gains expand to over 54% in late trading session. As of press time, the stock was up 48.04% to HK$1.51, with trading volume reaching HK$8.4778 million.\nAccording to public information, Hong Kong Austar Group operates as a technology-based pharmaceutical engineering solutions provider. As one of the group's main subsidiaries, Austar Life Sciences Products and Services Division encompasses nine business segments: sterile drug production contamination control consumables, equipment and services; environmental monitoring and detection systems; validation and stand-alone equipment; biological upstream process systems; single-use process systems; laboratory informatization; and life science consulting.\nAUSTAR's interim results showed shareholders' attributable profit of HK$24.999 million, representing a year-on-year increase of 325.37%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}